Anthrax Vaccines
Study findings from LigoCyte Pharmaceuticals Inc. broaden understanding of anthrax vaccines
Published in Medical Letter on the CDC and FDA, December 21st, 2008
Scientists discuss in 'A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge' new findings in anthrax. "Here we confirm that intranasal (IN) dry powder anthrax vaccine formulations are able to protect rabbits against aerosol challenge 9 weeks after a single immunization. The optimum dose of rPA in our dry powder anthrax vaccine formulation in rabbits was experimentally determined to be 150microg and therefore was chosen as the target dose for all subsequent experiments," investigators in the United States report.
"Rabbits received a single dose of either 150microg rPA, 150microg rPA+150microg of a conjugated 10-mer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Canadian Medical Association Journal
Risk of death may be higher with drug commonly used during cardiac surgery - Springer
Money motivates doctors to reduce ethnic differences in heart disease treatments - University of Exeter
New treatment hope for people with recurring depression - Aneurysm
Recent findings from Duke University highlight research in aneurysm - Biologics
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) - Cancer
New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
